Page 1514 - Williams Hematology ( PDFDrive )
P. 1514

1488  Part X:  Malignant Myeloid Diseases  Chapter 89:  Chronic Myelogenous Leukemia and Related Disorders           1489




                    947.  Lahortiga I, Akin C, Cools J, et al: Activity of imatinib in systemic mastocytosis with     980.  Tuohey EL: A case of splenomegaly with polymorphonuclear neutrophil hyperleuko-
                     chronic basophilic leukemia and a PRKG2-PDGFRB fusion. Haematologica 93:49,   cytosis. Am J Med Sci 160:18, 1920.
                     2008.                                                981.  Froberg MK, Brunning RD, Dorion P, et al: Demonstration of clonality in neutrophils
                    948.  Castro-Malaspina H, Schaison G, Brier J, et al: Philadelphia chromosome positive   using FISH in a case of chronic neutrophilic leukemia. Leukemia 12:623, 1998.
                     chronic myelocytic leukemia in children: Survival and prognostic factors.  Cancer     982.  Böhm J, Schaefer HE: Chronic neutrophilic leukemia:14 new cases of an uncommon
                     51:721, 1983.                                          myeloproliferative disorder. J Clin Pathol 55:862, 2002.
                    949.  Arico M, Biondi A, Pui C-H: Juvenile myelomonocytic leukemia. Blood 90:479, 1997.    983.  Standen GR, Steers FJ, Jones L: Clonality in chronic neutrophilic leukemia associated
                    950.  Neimeyer CM, Arico M, Basso A, et al: Chronic myelomonocytic leukemia in child-  with myeloma: Analysis using the X-linked probe M27 beta. J Clin Pathol 46:297, 1993.
                     hood. Blood 89:3535, 1997.                           984.  Bohm J, Kock S, Schaefer HE, Fisch P: Evidence of clonality in chronic neutrophilic
                    951.  Emanuel PD: Juvenile myelomonocytic leukemia and chronic myelomonocytic leuke-  leukaemia. J Clin Pathol 56:292, 2003.
                     mia. Leukemia 22:1335, 2008.                         985.  Yanagisawa K, Ohminami H, Sato M, et al: Neoplastic involvement of granulocytic
                    952.  Niemeyer CM, Kratz C: Juvenile myelomonocytic leukemia. Curr Oncol Rep 5:510,   lineage, not granulocytic-monocytic, monocytic, or erythrocytic lineage, in a patient
                     2003.                                                  with chronic neutrophilic leukemia. Am J Hematol 57:221, 1998.
                    953.  Busque L, Gilliland DG, Prchal JT, et al: Clonality in juvenile chronic myelogenous     986.  Hasegawa T, Suzuki K, Sakamoto C, et al: Expression of the inhibitor of apoptosis
                     leukemia. Blood 85:21, 1995.                           (IAP) family members in human neutrophils: Up-regulation of cIAP2 in chronic neu-
                    954.  Cooper LJN, Shannon KM, Loken MR, et al: Evidence that juvenile chronic myelo-  trophilic leukemia. Blood 101:1164, 2003.
                     monocytic leukemia can arise from a pluripotential stem cell. Blood 96:2310, 2000.    987.  Hasle H, Olesen G, Kerndrup G, et al: Chronic neutrophilic leukaemia in adolescence
                    955.  Emanuel PD: RAS pathway mutations in juvenile myelomonocytic leukemia. Acta   and young adulthood. Br J Haematol 94:628, 1996.
                     Haematol 119:207, 2008.                              988.  Elliott MA, Dewald GW, Tefferi A, Hanson CA: Chronic neutrophilic leukemia
                    956.  Guilbert-Douet N, Morel F, Le Bris M-J, et al: Somatic  PTPN11 mutation with a     (CNL): A clinical and pathological entity. Leukemia 15:35, 2001.
                     heterogeneous  clonal  origin  in  children  with  juvenile  myelomonocytic  leukemia.      989.  Reilly JT: Chronic neutrophilic leukaemia: A distinct clinical entity? Br J Haematol
                     Leukemia 18:1142, 2004.                                116:10, 2002.
                    957.  Gandre-Babbe S, Paluru P, Aribeana C, Chou ST, et al: Patient-derived induced     990.  Elliott MA: Chronic neutrophilic leukemia. Curr Hematol Rep 3:210, 2004.
                     pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelo-    991.  Gotlib J, Maxson JE, George TI, Tyner JW. The new genetics of chronic neutrophilic
                     monocytic leukemia. Blood 121:4925, 2013.              leukemia and atypical CML: Implications for diagnosis and treatment. Blood 122:1707,
                    958.  Miyauchi J, Asada M, Sasaki M, et al: Mutations of the N-ras gene in juvenile chronic   2013.
                     myelogenous leukemia. Blood 83:2248, 1994.           992.  Ortiz-Cruz K, Amog-Jones G, Salvatore JR: Chronic neutrophilic leukemia with JAK2
                    959.  Bader JL, Miller RW: Neurofibromatosis and childhood leukemia. J Pediatr 92:925,   gene mutation. Clin Commun Oncol 9:127, 2012.
                     1978.                                                993.  Fleischman AG, Maxson JE, Luty SB et al: The CSF3R T618I mutation causes a lethal
                    960.  Brodeur GM: The NF1 gene in myelopoiesis and childhood myelodysplastic syn-  neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Blood
                     drome. N Engl J Med 330:637, 1994.                     122:3628, 2013.
                    961.  Shannon KM: Loss of normal NF1 allele from the bone marrow of children with type     994.  Piliotis E, Kutas G, Lipton JH: Allogeneic bone marrow transplantation in the man-
                     1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597, 1994.  agement of chronic neutrophilic leukemia. Leuk Lymphoma 43:2051, 2002.
                    962.  Bollag G: Loss of NF1 results in activation of RAS signaling pathway and leads to     995.  Ito T, Kojima H, Otani K, et al: Chronic neutrophilic leukemia associated with mono-
                     aberrant growth in haematopoietic cells. Nat Genet 12:137, 1996.  clonal gammopathy of undetermined significance. Acta Haematol 95:140, 1996.
                    963.  Tartaglia M, Niemeyer CM, Fragale A, et al: Somatic mutations in PTPN11 in juvenile     996.  Vorobiof DA, Benjamin J, Kaplan H, Dvilansky A: Chronic granulocytic leukemia,
                     myelomonocytic leukemia, myelodysplastic syndrome and acute myeloid leukemia.   neutrophilic type with paraproteinemia (IgA type K). Acta Haematol 60:316, 1978.
                     Nat Genet 34:148, 2003.                              997.  Carcassonne Y, Gastaut JA, Sebahoun G, Gratecos N: Découverte simultanée chez
                    964.  Owen G, Lewis IJ, Morgan M, et al: Prognostic factors in juvenile chronic granulocytic   un même malade d’un myélome, d’une leucémie granuleuse (à polynucléaires neu-
                     leukaemia. Br J Cancer Suppl 18:S68, 1992.             trophils) et d’une maladie de Paget. Nouv Rev Fr Hematol 18:240, 1977.
                    965.  Estrov Z, Grunberger T, Chan HS, Freedman MH: Juvenile chronic myelogenous leu-    998.  Franchi F, Seminara P, Gruinchi G: Chronic neutrophilic leukemia and myeloma.
                     kemia. Characterization of the disease using cell cultures. Blood 67:1382, 1986.  Report on long survival. Tumori 70:105, 1984.
                    966.  Estrov Z, Dube ID, Chan HS, Freedman MH: Residual juvenile chronic myelogenous     999.  Lewis MJ, Oelbaum MH, Coleman M, Allen S: An association between chronic
                     leukemia cells detected in peripheral blood during clinical remission. Blood 70:1466,   neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding
                     1987.                                                  proteins. Br J Haematol 63:173, 1986.
                    967.  Emanuel PD, Bates LJ, Zhu SW, et al: The role of monocyte-derived hemopoietic     1000.  Rovira M, Cervantes F, Namdedeu B, Rozman C: Chronic neutrophilic leukaemia
                     growth factors in the regulation of myeloproliferation in juvenile chronic myeloge-  preceding for seven years the development of multiple myeloma. Acta Haematol 3:94,
                     nous leukemia. Exp Hematol 19:1017, 1991.              1990.
                    968.  Morerio C, Acquila M, Rosanda C, et al: HCMOGT-1 is a novel fusion partner to     1001.  Standen GR, Jasani B, Wagstaff M, Wardrop CAJ: Chronic neutrophilic leukemia and
                     PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2). Cancer Res   multiple myeloma. Cancer 66:162, 1990.
                     64:2649, 2004.                                       1002.  Nagai  M,  Oda  S,  Iwamoto  M,  et  al:  Granulocyte-colony  stimulating  factor
                    969.  Inoue S, Ravindranath Y, Thompson RI, et al: Cytogenetics of juvenile type chronic   concentrates in a patient with plasma cell dyscrasia and clinical features of chronic
                     granulocytic leukemia. Cancer 39:2017, 1977.           neutrophilic leukaemia. J Clin Pathol 49:858, 1996.
                    970.  Brodeur GM, Dow LW, Williams DL: Cytogenetic features of juvenile chronic myelog-    1003.  Dinçol G, Nalçaci M, Dogan O, et al: Coexistence of chronic neutrophilic leukemia
                     enous leukemia. Blood 53:812, 1979.                    with multiple myeloma. Leuk Lymphoma 43:649, 2002.
                    971.  Chan HS, Estrov Z, Weitzman SS, Freedman MH: The value of intensive combination     1004.  Masini L, Salvarani C, Macchioni P, et al: Chronic neutrophilic leukemia (CNL) with
                     chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol 5:1960, 1987.  karyotype abnormalities associated with plasma cell dyscrasia. Haematologica 77:277,
                    972.  Kang HJ, Shin HY, Choi HS, Ahn HS: Novel regimen for the treatment of juvenile   1992.
                     myelomonocytic leukemia (JMML). Leuk Res 28:167, 2004.    1005.  Pascucci M, Dorion P, Makary A, Froberg MK: Chronic neutrophilic leukemia evolv-
                    973.  Pui CH, Arico M: Isotretinoin for juvenile chronic myelogenous leukemia. N Engl J   ing from the myelodysplastic syndrome. Acta Haematol 98:163, 1997.
                     Med 332:1520, 1995.                                  1006.  Takamatsu Y, Kondo S, Inoue M, Tamura K: Chronic neutrophilic leukemia with dys-
                    974.  Bernard F, Thomas C, Emile JF, et al: Transient hematologic and clinical effects of   plastic features mimicking myelodysplastic syndrome. Int J Hematol 63:65, 1996.
                     E21R in a child with end-stage juvenile myelomonocytic leukemia. Blood 99:2615,     1007.  Higuchi T, Oba R, Endo M, et al: Transition of polycythemia vera to chronic neu-
                     2002.                                                  trophilic leukemia. Leuk Lymphoma 33:203, 1999.
                    975.  Locatelli F, Niemeyer C, Angelucci E, et al: Allogeneic bone marrow transplantation     1008.  Billio A, Venturi R, Morello E, et al: Chronic neutrophilic leukemia evolving from
                     for chronic myelomonocytic leukemia in childhood. J Clin Oncol 15:556, 1997.  polycythemia vera with multiple chromosome rearrangements: A case report.
                    976.  Manabe A, Okamura J, Yumura-Yagi K, et al: Allogeneic hematopoietic stem cell trans-  Haematologica 86:1225, 2001.
                     plantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on     1009.  Foa P, Iurlo A, Saglio G, et al: Chronic neutrophilic leukemia associated with
                     the criteria of the International JMML Working Group. Leukemia 16:645, 2002.  polycythemia vera. Br J Haematol 78:286, 1991.
                    977.  Locatelli F, Crotta A, Ruggeri A, et al: Analysis of risk factors influencing outcomes     1010.  Higuchi T, Oba R, Endo M, et al: Transition of polycythemia vera to chronic neu-
                     after cord blood transplantation in children with juvenile myelomonocytic leukemia:   trophilic leukemia. Leuk Lymphoma 33:203, 1999.
                     A EUROCORD, EBMT, EWOG-MDS, CIBMTR study. Blood 122:2135, 2013.    1011.  Iurlo A, Foa P, Mailo AT, et al: Polycythemia vera terminating in chronic neutrophilic
                    978.  Worth A, Rao K, Webb D, et al: Successful treatment of juvenile myelomonocytic   leukemia. Am J Hematol 35:139, 1990.
                     leukemia relapsing after stem cell transplantation using donor lymphocyte infusion.     1012.  Soda H, Kuriyama K, Tomonaga M, et al: Lymphoid crisis with T-cell phenotypes
                     Blood 101:1713, 2003.                                  in a patient with Philadelphia chromosome negative chronic myeloid leukemia. Br J
                    979.  Scrideli CA, Baruffi MR, Rogatto SR, et al: B lineage acute lymphoblastic leukemia   Haematol 59:671, 1985.
                     transformation in a child with juvenile myelomonocytic leukemia, type 1 neurofibro-    1013.  Kessler JF, Grogan TM, Greenberg BR: Philadelphia-chromosome-negative chronic
                     matosis and monosomy of chromosome 7. Possible implications in the leukemogene-  myelogenous leukemia with lymphoid stem cell blastic transformation. Am J Hematol
                     sis. Leuk Res 27:371, 2003.                            18:201, 1985.








          Kaushansky_chapter 89_p1437-1490.indd   1489                                                                  9/18/15   3:42 PM
   1509   1510   1511   1512   1513   1514   1515   1516   1517   1518   1519